1.jpg
BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference
20 nov. 2020 08h30 HE | BioDelivery Sciences International
RALEIGH, N.C., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
1.jpg
BioDelivery Sciences to Present Virtually and Host 1x1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18
11 nov. 2020 08h30 HE | BioDelivery Sciences International
RALEIGH, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
1.jpg
BioDelivery Sciences Reports Strong Q3 2020 Results
05 nov. 2020 08h00 HE | BioDelivery Sciences International
Total Company Net Revenue Increased 30% versus Prior Year Reaching a Record $39.4 Million Conference Call and Webcast Scheduled for 8:30 AM EST Today RALEIGH, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE)...
1.jpg
BioDelivery Sciences Announces $25 Million Share Repurchase Program
04 nov. 2020 17h31 HE | BioDelivery Sciences International
RALEIGH, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
1.jpg
BioDelivery Sciences Announces Appointment of Jeff Bailey as Permanent CEO
04 nov. 2020 17h11 HE | BioDelivery Sciences International
RALEIGH, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
1.jpg
BioDelivery Sciences to Report Third Quarter 2020 Financial Results on November 5, 2020
23 oct. 2020 08h00 HE | BioDelivery Sciences International
RALEIGH, N.C., Oct. 23, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...
1.jpg
BioDelivery Sciences Announces Five Scientific Poster Presentations at PAINWeek® 2020 National Conference on Pain Management
11 sept. 2020 08h00 HE | BioDelivery Sciences International
RALEIGH, N.C., Sept. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with...
1.jpg
BioDelivery Sciences to Present at Two Upcoming Investor Conferences
03 sept. 2020 08h00 HE | BioDelivery Sciences International
RALEIGH, N.C., Sept. 03, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with...
1.jpg
BioDelivery Sciences Reports Strong Q2 2020 Results
05 août 2020 07h45 HE | BioDelivery Sciences International
Second Quarter Total Company Net Revenue Increased 23% versus Prior Year to $36.6 Million Second Quarter BELBUCA® Net Sales Increased 34% versus Prior Year to $32.3 Million BELBUCA and Symproic®...
1.jpg
BioDelivery Sciences to Report Second Quarter 2020 Financial Results on August 5, 2020
27 juil. 2020 16h01 HE | BioDelivery Sciences International
RALEIGH, N.C., July 27, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious...